Yuto Suzuki

Jan 11, 2025 | abandomoviez.net | Yuto Suzuki

"Sakamoto Days" - Japón - Anime Puntúala Insertar Taro Sakamoto era el asesino más letal y respetado, temido por criminales y admirado por sus colegas. Pero todo cambió cuando se enamoró. Decidió retirarse, casarse, formar una familia y llevar una tranquila vida como dueño de una tienda... aunque con algunos kilos de más. Sin embargo, el pasado nunca desaparece del todo, y su identidad como un legendario sicario sigue persiguiéndolo. Ahora, como padre devoto, deberá usar sus habilidades para...

Nov 21, 2024 | telugustates.net | Filipa Lopes |Takeru Hokazono |Yuto Suzuki |Tatsuki Fujimoto

Over the years, manga has become increasingly accessible all around the world. In addition to more and more series being licensed, in general, it’s become easier than ever to read manga digitally thanks to the advent of manga platforms and apps, especially since many of them offer at least the latest chapters for free. It’s never been easier to read manga legally than it is now, and as such, some manga are far more worth someone’s time than others.

Aug 29, 2024 | semananews.com | Sam Rajan |Takeru Hokazono |Yuto Suzuki |Tite Kubo

Over the years, manga has become increasingly accessible all around the world. In addition to more and more series being licensed, in general, it’s become easier than ever to read manga digitally thanks to the advent of manga platforms and apps, especially since many of them offer at least the latest chapters for free. It’s never been easier to read manga legally than it is now, and as such, some manga are far more worth someone’s time than others.

Jul 31, 2024 | imdb.com | Yuto Suzuki

Legendary ex-hitman Taro Sakamoto bands with comrades to face off against the looming threat of assassins to ensure a peaceful life with his beloved family in this long-awaited anime adaptat...

Mar 18, 2024 | biorxiv.org | Yuto Suzuki |Andrew Hill |Elena Engel |Ann M. Granchelli

AbstractChronic obstructive pulmonary disease (COPD) affects 5-10% of the adult US population and is a major cause of mortality. Acute exacerbations of COPD (AECOPDs) are a major driver of COPD morbidity and mortality, but there are no cost-effective methods to identify early AECOPDs when treatment is most likely to reduce the severity and duration of AECOPDs. We conducted the first long-term (> 12 months), real-time monitoring studies of AECOPD with wearable sensors and self-reporting.